Loading insider details...
Beta
Latest Form 4 (Oct 17, 2026): Grant/Award of 250,000 MBRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 17, 2026 | Moleculin Biotech, Inc. (MBRX) | Grant/Award | 250,000 | n/a |
| Aug 5, 2026 | Moleculin Biotech, Inc. (MBRX) | Purchase | 173,333 | n/a |
| Jun 25, 2026 | Moleculin Biotech, Inc. (MBRX) | Exercise/Conversion | 44 | n/a |
| Nov 14, 2025 | Moleculin Biotech, Inc. (MBRX) | Grant/Award | 200,000 | n/a |
| Nov 7, 2025 | Moleculin Biotech, Inc. (MBRX) | Exercise/Conversion | 8,750 | n/a |
| Jun 23, 2025 | Moleculin Biotech, Inc. (MBRX) | Exercise/Conversion | 1,078 | n/a |
| Nov 7, 2024 | Moleculin Biotech, Inc. (MBRX) | Grant/Award | 40,000 | n/a |
| Jun 25, 2024 | Moleculin Biotech, Inc. (MBRX) | Exercise/Conversion | 1,766 | n/a |
| Jun 21, 2024 | Moleculin Biotech, Inc. (MBRX) | Exercise/Conversion | 1,078 | n/a |
| Jun 26, 2023 | Moleculin Biotech, Inc. (MBRX) | Grant/Award | 100,000 | n/a |